Allogene Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2018 | — | $-2.6M | $-2.6M |
| Jun 2018 | — | $-135.0M | $-134.9M |
| Sep 2018 | — | $-22.2M | $-43.5M |
| Dec 2018 | — | $-33.0M | $-30.5M |
| Mar 2019 | — | $-36.5M | $-31.6M |
| Jun 2019 | — | $-46.0M | $-41.2M |
| Sep 2019 | — | $-55.0M | $-50.7M |
| Dec 2019 | — | $-64.6M | $-61.0M |
| Mar 2020 | $0 | $-57.7M | $-54.5M |
| Jun 2020 | $0 | $-63.2M | $-61.0M |
| Sep 2020 | $0 | $-68.0M | $-66.2M |
| Dec 2020 | $0 | $-69.4M | $-134.7M |
| Mar 2021 | $38.3M | $-33.2M | $-33.0M |
| Jun 2021 | $44.0K | $-71.0M | $-70.9M |
| Sep 2021 | $49.0K | $-77.7M | $-78.2M |
| Dec 2021 | $75.7M | $1.7M | $86.0K |
| Mar 2022 | $39.0K | $-80.0M | $-78.6M |
| Jun 2022 | $64.0K | $-76.6M | $-80.3M |
| Sep 2022 | $27.0K | $-82.5M | $-84.2M |
| Dec 2022 | $26.0K | $-96.4M | $-97.3M |
| Mar 2023 | $30.0K | $-99.1M | $-100.0M |
| Jun 2023 | $22.0K | $-80.5M | $-79.2M |
| Sep 2023 | $22.0K | $-63.0M | $-62.3M |
| Dec 2023 | $21.0K | $-85.1M | $-85.8M |
| Mar 2024 | $22.0K | $-69.5M | $-65.0M |
| Jun 2024 | $0 | $-71.4M | $-66.4M |
| Sep 2024 | $0 | $-71.8M | $-66.3M |
| Dec 2024 | $0 | $-60.5M | $-59.9M |
| Mar 2025 | $0 | $-65.2M | $-59.7M |
| Jun 2025 | $0 | $-56.8M | $-50.9M |
| Sep 2025 | $0 | $-44.9M | $-41.4M |
| Dec 2025 | $0 | $-42.4M | $-38.8M |
| Mar 2026 | $800.0K | $-46.1M | $-42.6M |
| Jun 2026 | $4.6M | $-46.9M | $-42.7M |